sglt2 inhibitors vs glp-1 agonists SGLT-2 and Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Renal and urothelial cancer risks

Description

Typically decreases in severity after 2-4 weeks of treatment Constipation When it happens: Often develops gradually after starting treatment How to manage it: Gradually increase fiber intake

It will also be important to establish whether lower doses continue to protect against weight regain, and which patients benefit most from switching to oral therapies

A novel protein, P9, derived from Akkermansia muciniphila , has been shown to stimulate GLP-1 secretion and enhance glucose homeostasis in mice subjected to a high-fat diet (HFD) ( L

Results: Based on the small intestinal transcriptome of geniposide, a recognized small-molecule GLP-1R agonist, we identified that cinchonine exerted GLP-1R agonist-like effects

For instance, a Whats more, While more research is needed, some GLP-1 medications may be more effective than others when it comes to blood sugar and weight management in people with type 2 diabetes